Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2019

Payables and Accruals [Abstract]

Schedule of Accrued Expenses

As of September 30, 2019 and December 31, 2018, the Company's accrued expenses balance consists of the following (in thousands): 

	September 30, 2019		December 31, 2018
Accrued clinical trial expenses	$	4,988	$	6,635
Accrued professional fees	9,421		13,398
Accrued technical operation expenses	10,176		9,371
Accrued royalty payable	1,830		409
Accrued interest payable	1,663		3,631
Accrued sales allowances and related costs	4,640		818
Accrued construction costs	4,693		2,946
Other accrued expenses	1,497		1,046
	$	38,908	$	38,254